Industry balks at Indian ministry's call to 'pay clinical trial compensation or go'
This article was originally published in Scrip
Executive Summary
India's health ministry has notified new draft trial compensation rules that plan to 'restrict' sponsors, clinical research organisations (CROs) or local representatives of foreign sponsors from conducting further clinical trials in the country if they fail to compensate participants for trial-related injuries or their heirs in case of deaths during such studies.